|
| Exchange Received Time 10/09/2018 15:51:59 Exchange Disseminated Time 10/09/2018 15:52:06 Time Taken 00:00:07 | This is to inform you that one of the wholly owned subsidiaries of the Company has agreed to acquire shares of Tarsius Pharma Ltd, ('Tarsius'), Israel, by way of subscription of 345,622 ordinary shares of nominal value of NIS 0.01 each, representing 18.75% of shares of Tarsius, on a fully diluted basis.
The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, is attached as per 'Annexure A'.
This is for your information and record.
|
|
|